vs

Side-by-side financial comparison of Axos Financial, Inc. (AX) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

Axos Financial, Inc. is the larger business by last-quarter revenue ($392.2M vs $220.8M, roughly 1.8× UNIVERSAL TECHNICAL INSTITUTE INC). Axos Financial, Inc. runs the higher net margin — 31.8% vs 5.8%, a 26.0% gap on every dollar of revenue. Over the past eight quarters, Axos Financial, Inc.'s revenue compounded faster (16.1% CAGR vs 9.5%).

Axos Financial is an American bank holding company based in Las Vegas, Nevada and is the parent of Axos Bank, a direct bank. It also offers registered investment adviser services and an electronic trading platform.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

AX vs UTI — Head-to-Head

Bigger by revenue
AX
AX
1.8× larger
AX
$392.2M
$220.8M
UTI
Higher net margin
AX
AX
26.0% more per $
AX
31.8%
5.8%
UTI
Faster 2-yr revenue CAGR
AX
AX
Annualised
AX
16.1%
9.5%
UTI

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
AX
AX
UTI
UTI
Revenue
$392.2M
$220.8M
Net Profit
$124.7M
$12.8M
Gross Margin
Operating Margin
7.1%
Net Margin
31.8%
5.8%
Revenue YoY
9.6%
Net Profit YoY
18.5%
-42.1%
EPS (diluted)
$2.15
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AX
AX
UTI
UTI
Q1 26
$392.2M
Q4 25
$385.1M
$220.8M
Q3 25
$323.4M
$222.4M
Q2 25
$321.4M
$204.3M
Q1 25
$308.8M
$207.4M
Q4 24
$307.9M
$201.4M
Q3 24
$320.7M
$196.4M
Q2 24
$290.9M
$177.5M
Net Profit
AX
AX
UTI
UTI
Q1 26
$124.7M
Q4 25
$128.4M
$12.8M
Q3 25
$112.4M
$18.8M
Q2 25
$110.7M
$10.7M
Q1 25
$105.2M
$11.4M
Q4 24
$104.7M
$22.2M
Q3 24
$112.3M
$18.8M
Q2 24
$104.9M
$5.0M
Operating Margin
AX
AX
UTI
UTI
Q1 26
Q4 25
45.6%
7.1%
Q3 25
46.3%
11.2%
Q2 25
48.5%
6.9%
Q1 25
47.9%
8.1%
Q4 24
48.8%
13.6%
Q3 24
49.6%
13.3%
Q2 24
49.6%
4.2%
Net Margin
AX
AX
UTI
UTI
Q1 26
31.8%
Q4 25
33.3%
5.8%
Q3 25
34.7%
8.4%
Q2 25
34.4%
5.2%
Q1 25
34.1%
5.5%
Q4 24
34.0%
11.0%
Q3 24
35.0%
9.6%
Q2 24
36.0%
2.8%
EPS (diluted)
AX
AX
UTI
UTI
Q1 26
$2.15
Q4 25
$2.22
$0.23
Q3 25
$1.94
$0.33
Q2 25
$1.89
$0.19
Q1 25
$1.81
$0.21
Q4 24
$1.80
$0.40
Q3 24
$1.93
$0.35
Q2 24
$1.75
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AX
AX
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$3.1B
$335.9M
Total Assets
$29.2B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AX
AX
UTI
UTI
Q1 26
Q4 25
$1.0B
$162.8M
Q3 25
$2.6B
$169.1M
Q2 25
$1.9B
$70.7M
Q1 25
$2.0B
$96.0M
Q4 24
$2.4B
$172.0M
Q3 24
$2.6B
$161.9M
Q2 24
$2.0B
$115.5M
Total Debt
AX
AX
UTI
UTI
Q1 26
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$312.7M
$73.8M
Q1 25
$377.4M
$94.4M
Q4 24
$358.7M
$120.1M
Q3 24
$313.5M
$125.7M
Q2 24
$325.7M
$137.3M
Stockholders' Equity
AX
AX
UTI
UTI
Q1 26
$3.1B
Q4 25
$2.9B
$335.9M
Q3 25
$2.8B
$328.1M
Q2 25
$2.7B
$306.8M
Q1 25
$2.6B
$293.9M
Q4 24
$2.5B
$280.0M
Q3 24
$2.4B
$260.2M
Q2 24
$2.3B
$239.4M
Total Assets
AX
AX
UTI
UTI
Q1 26
$29.2B
Q4 25
$28.2B
$834.0M
Q3 25
$27.4B
$826.1M
Q2 25
$24.8B
$740.8M
Q1 25
$24.0B
$720.4M
Q4 24
$23.7B
$753.8M
Q3 24
$23.6B
$744.6M
Q2 24
$22.9B
$706.0M
Debt / Equity
AX
AX
UTI
UTI
Q1 26
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.12×
0.24×
Q1 25
0.14×
0.32×
Q4 24
0.14×
0.43×
Q3 24
0.13×
0.48×
Q2 24
0.14×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AX
AX
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AX
AX
UTI
UTI
Q1 26
Q4 25
$104.1M
$3.1M
Q3 25
$118.4M
$57.1M
Q2 25
$490.3M
$18.1M
Q1 25
$73.7M
$-789.0K
Q4 24
$162.5M
$23.0M
Q3 24
$70.8M
$67.5M
Q2 24
$305.5M
$10.0M
Free Cash Flow
AX
AX
UTI
UTI
Q1 26
Q4 25
$85.4M
$-19.2M
Q3 25
$109.3M
$40.6M
Q2 25
$436.1M
$6.8M
Q1 25
$65.1M
$-11.7M
Q4 24
$156.4M
$19.6M
Q3 24
$53.0M
$60.0M
Q2 24
$269.5M
$3.0M
FCF Margin
AX
AX
UTI
UTI
Q1 26
Q4 25
22.2%
-8.7%
Q3 25
33.8%
18.3%
Q2 25
135.7%
3.4%
Q1 25
21.1%
-5.7%
Q4 24
50.8%
9.7%
Q3 24
16.5%
30.6%
Q2 24
92.6%
1.7%
Capex Intensity
AX
AX
UTI
UTI
Q1 26
Q4 25
4.9%
10.1%
Q3 25
2.8%
7.4%
Q2 25
16.9%
5.5%
Q1 25
2.8%
5.3%
Q4 24
2.0%
1.7%
Q3 24
5.5%
3.8%
Q2 24
12.4%
4.0%
Cash Conversion
AX
AX
UTI
UTI
Q1 26
Q4 25
0.81×
0.24×
Q3 25
1.05×
3.04×
Q2 25
4.43×
1.69×
Q1 25
0.70×
-0.07×
Q4 24
1.55×
1.04×
Q3 24
0.63×
3.58×
Q2 24
2.91×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AX
AX

Net Interest Income$306.3M78%
Noninterest Income$86.0M22%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons